Ilse Vaneycken - Concepedia

Author

Ilse Vaneycken

Vrije Universiteit Brussel

Also Known As

I. Vaneycken, Ilse Vaneycken

Publications

Citations

H-Index

Concepts

All Affiliations

Vrije Universiteit Brussel Universitair Ziekenhuis Brussel Vlaams Instituut voor Biotechnologie Cliniques Universitaires Saint-Luc VIB-UGent Center for Inflammation Research

About

Ilse Vaneycken is an author at Vrije Universiteit Brussel specializing in radiation oncology, tumor biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	452
2	Engineering	2	2	420
3	Health Sciences	2	2	146
4	Biomedical Engineering	1	1	306
5	Biomolecular Engineering	1	1	306

Ilse Vaneycken

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Phase I Study of <sup>68</sup>Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma Marleen Keyaerts, Catarina Xavier, Johannes Heemskerk, Journal of Nuclear Medicine	2015	419
Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer Ilse Vaneycken, Nick Devoogdt, Naomi Van Gassen, The FASEB Journal NanoparticlesBreast OncologyEngineeringBiomedical EngineeringLead Compound	2011	306
Synthesis, Preclinical Validation, Dosimetry, and Toxicity of <sup>68</sup>Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer Catarina Xavier, Ilse Vaneycken, Matthias D’Huyvetter, Journal of Nuclear Medicine	2013	219
Comparison of the Biodistribution and Tumor Targeting of Two <sup>99m</sup>Tc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT Lea Olive Tchouate Gainkam, Lieven Huang, Vicky Caveliers, Journal of Nuclear Medicine	2008	216
PET Imaging of Macrophage Mannose Receptor–Expressing Macrophages in Tumor Stroma Using <sup>18</sup>F-Radiolabeled Camelid Single-Domain Antibody Fragments Anneleen Blykers, Steve Schoonooghe, Catarina Xavier, Journal of Nuclear Medicine	2015	153
In Vitro Analysis and In Vivo Tumor Targeting of a Humanized, Grafted Nanobody in Mice Using Pinhole SPECT/Micro-CT Ilse Vaneycken, Jochen Govaert, Cécile Vincke, Journal of Nuclear Medicine	2010	123
Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients Matthias D’Huyvetter, Jens De Vos, Vicky Caveliers, Journal of Nuclear Medicine Breast OncologyHealthy SubjectsTumor BiologyRadiation MedicineBreast Cancer Patients	2020	116
18F-nanobody for PET imaging of HER2 overexpressing tumors Catarina Xavier, Anneleen Blykers, Ilse Vaneycken, Nuclear Medicine and Biology NanomedicineEngineeringOncologic ImagingPet ImagingBiomedical Imaging	2016	114
Development of <sup>177</sup>Lu‐nanobodies for radioimmunotherapy of HER2‐positive breast cancer: evaluation of different bifunctional chelators Matthias D’Huyvetter, An Aerts, Catarina Xavier, Contrast Media & Molecular Imaging	2012	79
Site-Specific Labeling of His-Tagged Nanobodies with 99mTc: A Practical Guide Catarina Xavier, Nick Devoogdt, Sophie Hernot, Methods in molecular biology	2012	47

Page 1